ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 95 filers reported holding ORAMED PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $299,000 | – | 22,310 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MORGAN JESS S & CO INC | 315,301 | $1,444,000 | 1.50% |
| Private Portfolio Partners LLC | 54,010 | $247,366 | 0.07% |
| Knoll Capital Management, LLC | 20,000 | $92,000 | 0.05% |
| Urban Wealth Management, LLC | 2,858 | $13,000 | 0.04% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 100,216 | $459,000 | 0.04% |
| XTX Topco Ltd | 18,174 | $83,000 | 0.03% |
| Rossmore Private Capital | 40,661 | $186,000 | 0.03% |
| Ergoteles LLC | 224,700 | $1,029,000 | 0.03% |
| ETF MANAGERS GROUP, LLC | 87,365 | $393,000 | 0.01% |
| Belvedere Trading LLC | 40,690 | $343,000 | 0.01% |